577-nm Diode Laser in the Treatment of Non -Inflammatory Acne
Effectiveness and Safety of 577-nm Diode Laser in the Treatment of Non -Inflammatory Acne
1 other identifier
interventional
50
1 country
1
Brief Summary
The aim of this study is to evaluate the clinical efficacy and safety of the 577 nm diode laser in the treatment of non -inflammatory acne.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 27, 2025
CompletedStudy Start
First participant enrolled
March 29, 2025
CompletedFirst Posted
Study publicly available on registry
April 3, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedApril 3, 2025
February 1, 2025
3 months
March 27, 2025
March 27, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Reduction in the number of comedones, measured through clinical assessment before and after treatment
3 months
Study Arms (2)
All patients will be treated with sessions of the 577 nm Diode laser on one side of the face
ACTIVE COMPARATORAll patients will be treated with sessions of the 577 nm Diode laser on one side of the face and on the other side serve as a control
other side of the face serve as a control arm without interventions
NO INTERVENTIONAll patients will be treated with sessions of the 577 nm Diode laser on one side of the face and on the other side serve as a control without any interventions
Interventions
All patients will be treated with sessions of the 577 nm Diode laser on one side of the face and on the other side serve as a control
Eligibility Criteria
You may qualify if:
- Patients with acne comedones
- Patients' ages range from 18-40 years.
- Minimum 10 comedonal lesions on both half of the face
You may not qualify if:
- Patients with systemic disease interfere with healing.
- Patients with Photosensitivity.
- Pregnant or lactating females.
- Previous topical, systemic, laser, surgical treatment and comedogenic drugs in the last 3 months.
- Skin cancer or suspicious lesions.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Azhar Assuit university hospital
Asyut, Assuit, 71511, Egypt
Related Publications (4)
Barbieri JS, Spaccarelli N, Margolis DJ, James WD. Approaches to limit systemic antibiotic use in acne: Systemic alternatives, emerging topical therapies, dietary modification, and laser and light-based treatments. J Am Acad Dermatol. 2019 Feb;80(2):538-549. doi: 10.1016/j.jaad.2018.09.055. Epub 2018 Oct 5.
PMID: 30296534BACKGROUNDMavranezouli I, Daly CH, Welton NJ, Deshpande S, Berg L, Bromham N, Arnold S, Phillippo DM, Wilcock J, Xu J, Ravenscroft JC, Wood D, Rafiq M, Fou L, Dworzynski K, Healy E. A systematic review and network meta-analysis of topical pharmacological, oral pharmacological, physical and combined treatments for acne vulgaris. Br J Dermatol. 2022 Nov;187(5):639-649. doi: 10.1111/bjd.21739. Epub 2022 Aug 22.
PMID: 35789996BACKGROUNDMelnik BC. Acne Transcriptomics: Fundamentals of Acne Pathogenesis and Isotretinoin Treatment. Cells. 2023 Nov 10;12(22):2600. doi: 10.3390/cells12222600.
PMID: 37998335BACKGROUNDAlsohaimi AO, Alghamdi A, Alghamdi RS, Alghamdi AH, Alkhathami AM, Alghamdi MA, Alghamdi SA, Alzahrani NM, Alghamdi NS. Prevalence of Acne Vulgaris in Adolescents and Young Adults in Al-Baha Region, Saudi Arabia. Cureus. 2024 Oct 12;16(10):e71293. doi: 10.7759/cureus.71293. eCollection 2024 Oct.
PMID: 39529772BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- resident physician at dermatology department at azhar assuit university hospital
Study Record Dates
First Submitted
March 27, 2025
First Posted
April 3, 2025
Study Start
March 29, 2025
Primary Completion
July 1, 2025
Study Completion
August 1, 2025
Last Updated
April 3, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share